Lapatinib Recruiting Phase 2 Trials for Small Cell Lung Carcinoma / Lung Cancer Non-Small Cell Cancer (NSCLC) / Thymic Carcinoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01306045Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies